Genitourinary Radiology: Page 8

How deep learning can help predict cancer recurrence
By Irina Grigorescu
Researchers have shown that a deep-learning algorithm can be used to extract interpretable features from annotation-free histopathology images from prostate cancer patients. Their framework outperformed the prediction of biochemical recurrence using conventional methods.
February 13, 2020
2020 02 13 19 51 3108 2020 02 14 Pathology 20200213191628
EANM offers prostate cancer care prerequisites
By AuntMinnieEurope.com staff writers
The European Association of Nuclear Medicine (EANM) is among the contributors to a guide for oncology care providers, patient groups, policymakers, and managers on what healthcare systems need to provide high-quality prostate cancer care.
February 4, 2020
2019 05 03 20 23 2154 Prostate 3 D 400
SPL promotes milestone with Ferrotran prostate agent
By AuntMinnieEurope.com staff writers
SPL Medical of the Netherlands is highlighting a milestone in the development of its Ferrotran MRI contrast agent for detecting lymph node metastases from prostate cancer.
December 12, 2019
2016 10 04 11 38 34 158 Prostate 400
3D printing boosts treatment of urethral injuries
By Abraham Kim
Patient-specific 3D-printed models based on pelvic CT scans improve clinicians' understanding of complex pelvic anatomy and their ability to plan surgical repair for urethral injuries more than conventional imaging, according to a study published online in the Turkish Journal of Urology.
November 25, 2019
2019 11 25 22 20 6195 3 D Printed Pelvis Lateral Cropped 20191125223515
Multiparametric MRI targets timely tumor differentiation
By Frances Rylands-Monk
With greater use of cross-sectional imaging, many more renal masses are detected in routine practice. Accurate and early characterization of these masses with multiparametric MRI could soon be pivotal in patient management. New protocols are now gaining ground, but clinical validation is ongoing, according to Dr. Nicolas Grenier.
October 20, 2019
2019 10 18 17 51 6791 Grenier Thumb
GE, Theragnostics partner on PSMA agent
By AuntMinnieEurope.com staff writers
GE Healthcare and Theragnostics have signed a global partnership to develop a new prostate-specific membrane antigen (PSMA) PET/CT imaging agent.
October 8, 2019
2016 10 04 11 38 34 158 Prostate 400
Ga-68 PSMA PET/CT corrects therapy, saves money
By Wayne Forrest
Having recurrent prostate cancer patients undergo gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT can help direct clinicians to effectual curative treatment options that also are cost effective, according to a study by German researchers published in the October issue of the Journal of Nuclear Medicine.
October 8, 2019
2019 05 03 20 23 2154 Prostate 3 D 400
Theragnostics promotes prostate cancer study
By AuntMinnieEurope.com staff writers
Radiopharmaceuticals firm Theragnostics is reporting encouraging results from a phase II clinical study on the efficacy of diagnostic imaging with gallium-68 (Ga-68) tris(hydroxypyridinone) prostate-specific membrane antigen (THP-PSMA) PET/CT for prostate cancer.
October 1, 2019
2016 10 04 11 38 34 158 Prostate 400
Swiss cast new light on prostate cancer analysis
By Wayne Forrest
Researchers from Zurich have found gallium-68 prostate-specific membrane antigen offers better sensitivity, while multiparametric MRI provides better specificity, especially when determining tumor cell spread beyond the lymph node capsule or when prostate cancer extends into the seminal vesicles.
September 15, 2019
2018 01 15 20 27 2375 Swiss Flag 400
Ga-68 PMSA PET/CT aids in prostate cancer recurrence
By Wayne Forrest
Italian researchers have created a gallium-68 (Ga-68) prostate-specific membrane antigen (PSMA) PET/CT-based model to accurately predict which prostate cancer patients are likely to show recurrence. Their study was published on 6 September in the European Journal of Nuclear Medicine and Molecular Imaging.
September 11, 2019
2017 10 16 18 44 6737 Italian Flag 400
Support grows for mpMRI before prostate biopsy
By Kate Madden Yee
A U.K. study has shown that the use of multiparametric MRI (mpMRI) in suspected cases of prostate cancer can cut unnecessary biopsies by more than a third and boost the detection of clinically significant disease by more than 50%. The findings were published online on 7 August in JAMA Network Open.
August 12, 2019
2019 05 03 20 23 2154 Prostate 3 D 400
French team uses 3D printing for kidney cancer surgery
By AuntMinnieEurope.com staff writers
French researchers have created patient-specific 3D-printed anatomical models to facilitate presurgical planning and patient consultation for kidney-sparing surgery.
July 15, 2019
2019 07 16 17 09 3025 2016 07 16 3 D Printed Kidney 20190716174649
Previous Page
Page 8 of 22
Next Page